Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,588,704
-$3,134,986 QoQ
Shares Held
118,422
-51.7% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#93
of 242 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $494,895,363 across 45 Biotechnology names. SNDX ranks #38 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
233,171 | $62,191,369 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
219,596 | $53,750,512 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
160,768 | $38,740,264 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
308,385 | $29,219,478 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
143,222 | $26,822,616 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
253,358 | $18,870,103 | |
| 7 | CYTK |
Cytokinetics Inc
|
191,686 | $16,329,730 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,313 | $15,739,615 |
All Filings in SNDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,588,704 | 118,422 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,723,690 | 245,021 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,104,736 | 242,967 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,946,067 | 256,488 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $11,381,118 | 926,424 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,734,834 | 206,871 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,160,267 | 423,910 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,952,439 | 387,357 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,676,917 | 658,694 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $12,869,252 | 595,523 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $39,425,212 | 2,715,235 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $45,469,106 | 2,172,437 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $41,113,290 | 1,946,652 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $46,182,435 | 1,814,634 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,976,424 | 1,289,073 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,173,976 | 580,768 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $35,513,892 | 2,043,377 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $46,045,877 | 2,103,512 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $35,482,263 | 1,856,738 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,827,606 | 2,144,881 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $33,187,315 | 1,484,227 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||